Abstract:R-loops are formed during transcription when the nascent RNA generated by RNA polymerases hybridizes with its complementary DNA template, giving rise to a region of DNA : RNA hybrid and a displaced single-stranded DNA. R-loops are stable structures that have important beneficial physiological functions, but also could pose a threat to genomic stability. Unscheduled R-loops induce cell cycle checkpoint activation, DNA damage, and chromosome rearrangement in mammalian cells. R-loops expose unstable single-stranded DNA, which is prone to transcription-related mutations and recombination. R-loops may also directly block DNA replication, leading to DNA double strand breaks. Abnormal accumulations of R-loops have been found in some syndromes, human neurological disorders, and cancers. On the other hand, R-loops also play positive roles in physiological processes, such as epigenetic modification, DNA repair, gene regulation and mitochondrial stability. R-loops forming on transcription-termination regions, promote RNA polymerase pausing before termination. R-loops are regulated delicately in cells. Collisions between replication and transcription cause accumulation of R-loops. Replication stress, DNA damage and RNA Pol II pausing also induce R-loop formation. To resolve R-loops when they form, cell evolve numerous dissolution mechanisms. Ribonuclease RNase H1 and RNase H2 bind to R-loops and then catalyze the cleavage of RNA. Helicases, such as SETX, DHX9, DDX21, unwind the RNA from the R-loops. Defects in RNA processing factors, chromatin modulators, DNA repair proteins, cause accumulation of R-loops, suggesting they are involved in R-loop regulations. To detect R-loops, several methods have been developed and are mainly based on the S9.6 antibody and the HBD domain of RNase H1, however, both of them possess some issues. Understanding the regulatory mechanisms of R-loop formation and clearance could help us better know how cells maintain genomic stability and prevent disease development. In this review article, we summarized functions and regulations of R-loops. We also discussed methodologies used to detect R-loops. Finally, we proposed some future perspectives of R-loop research.

N 2-Alkyl-dG lesions elicit R-loop accumulation in the genome

The Impact of Minor-Groove N2-Alkyl-2'-deoxyguanosine Lesions on DNA Replication in Human Cells.

NKAP Acts with HDAC3 to Prevent R-loop Associated Genome Instability

DDX18 prevents R-loop-induced DNA damage and genome instability via PARP-1

In vivo detection and replication studies of α-anomeric lesions of 2'-deoxyribonucleosides.

Update on R-loops in genomic integrity: Formation, functions, and implications for human diseases

Syntheses and characterizations of the in vivo replicative bypass and mutagenic properties of the minor-groove O2-alkylthymidine lesions.

DNA Polymerase η Promotes the Transcriptional Bypass of N 2 -Alkyl-2′-deoxyguanosine Adducts in Human Cells

RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability

R loops: new modulators of genome dynamics and function

HMGB3 and SUB1 Bind to and Facilitate the Repair of N2-Alkylguanine Lesions in DNA

NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21

Looping forward: exploring R‐loop processing and therapeutic potential

Mechanism Of Dna Alkylation-Induced Transcriptional Stalling, Lesion Bypass, And Mutagenesis

DNA Polymerase Η Promotes the Transcriptional Bypass of N2-Alkyl-2'-deoxyguanosine Adducts in Human Cells.

Cytotoxic and Mutagenic Properties of Minor-Groove O2-alkylthymidine Lesions in Human Cells.

Functions and Regulations of R-loop

Impact of Tobacco-Specific Nitrosamine–derived DNA Adducts on the Efficiency and Fidelity of DNA Replication in Human Cells

Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions

Bridging the gap: R-loop mediated genomic instability and its implications in neurological diseases

DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy